For example, a chimeric anti-CD147 antibody (CNTO3899) directed against the extracellular domains of CD147 inhibited tumor growth in a SCC-1 xenograft model of HNSCC, and even more so when combined with radiotherapy (147). Here, BSG is linked to head and neck squamous cell carcinoma.